Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (231-240 of 263) with videos related to

Pageof 27
Sort By:
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
HIV Medicine|March 28, 2008
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell countsE De Lazzari, A León, J A Arnaiz, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovirK Theys, J Vercauteren, J Snoeck, et al.
AIDS (London, England)|April 19, 2000
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavirK Van Laethem, M Witvrouw, J Balzarini, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study GroupJ M Gatell, J González-Lahoz, B Clotet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 28, 2017
Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with menJ Coll, S Videla, A Leon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
AIDS (London, England)|November 14, 1998
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countriesJ C Schmit, K Van Laethem, L Ruiz, et al.
JAMA|June 27, 1998
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA PanelM S Hirsch, B Conway, R T D'Aquila, et al.
JAMA|May 18, 2000
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA PanelM S Hirsch, F Brun-Vézinet, R T D'Aquila, et al.
Pageof 27

Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
HIV Medicine|March 28, 2008
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell countsE De Lazzari, A León, J A Arnaiz, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovirK Theys, J Vercauteren, J Snoeck, et al.
AIDS (London, England)|April 19, 2000
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavirK Van Laethem, M Witvrouw, J Balzarini, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study GroupJ M Gatell, J González-Lahoz, B Clotet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 28, 2017
Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with menJ Coll, S Videla, A Leon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapyA Tuldrà, C R Fumaz, M J Ferrer, et al.
AIDS (London, England)|November 14, 1998
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countriesJ C Schmit, K Van Laethem, L Ruiz, et al.
JAMA|June 27, 1998
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA PanelM S Hirsch, B Conway, R T D'Aquila, et al.
JAMA|May 18, 2000
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA PanelM S Hirsch, F Brun-Vézinet, R T D'Aquila, et al.
Pageof 27